Large-scale cell line profiling of drugs provides dose-response curves that contain numerous lesser-considered parameters. Understanding the reasons for systematic variation in these parameters offers new ways to compare drugs and potentially to guide improved drug profiles.
References
Fallahi-Sichani, M., Honarnejad, S., Heiser, L.M., Gray, J.W. & Sorger, P.K. Nat. Chem. Biol. 9, 708–714 (2013).
Monks, A. et al. J. Natl. Cancer Inst. 83, 757–766 (1991).
Scherf, U. et al. Nat. Genet. 24, 236–244 (2000).
Covell, D.G. PLoS ONE 7, e44631 (2012).
Barretina, J. et al. Nature 483, 603–607 (2012).
Basu, A. et al. Cell 154, 1151–1161 (2013).
Sampah, M.E.S., Shen, L., Jilek, B.L. & Siliciano, R.F. Proc. Natl. Acad. Sci. USA 108, 7613–7618 (2011).
Shi, J., Orth, J.D. & Mitchison, T. Cancer Res. 68, 3269–3276 (2008).
Rabow, A.A., Shoemaker, R.H., Sausville, E.A. & Covell, D.G. J. Med. Chem. 45, 818–840 (2002).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Jenkins, J. Rethinking cellular drug response. Nat Chem Biol 9, 669–670 (2013). https://doi.org/10.1038/nchembio.1365
Published:
Issue Date:
DOI: https://doi.org/10.1038/nchembio.1365
- Springer Nature America, Inc.